Biogen

Founded in 1978, Biogen is a pioneer in biotechnology, driven by a mission to change the lives of patients suffering from neurological disorders and neurodegenerative diseases. With a strong commitment to research and innovation, Biogen focuses on transforming the treatment landscape through groundbreaking biopharmaceuticals that address unmet medical needs.

Headquartered in Cambridge, Massachusetts, Biogen operates with an impressive team of over 8,200 employees worldwide, each contributing to its legacy of medical breakthroughs. The company’s expertise in neurology has cemented its position as a leader in the field, consistently pushing the boundaries of science to develop therapies that improve patients' lives.

Under the leadership of CEO Christopher A. Viehbacher, Biogen remains steadfast in its dedication to advancing research and delivering innovative solutions. The company's robust pipeline and strategic partnerships illustrate its unwavering focus on addressing complex neurological conditions, ensuring that Biogen continues to make significant impacts within the biopharmaceutical industry.